Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck ROE 2010-2024 | MKKGY

Current and historical return on equity (ROE) values for Merck (MKKGY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Merck ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $2.93B $31.22B 9.64%
2024-06-30 $2.84B $30.82B 9.39%
2024-03-31 $2.96B $30.48B 9.90%
2023-12-31 $3.06B $28.96B 10.44%
2023-09-30 $3.09B $30.80B 10.70%
2023-06-30 $3.22B $29.19B 11.36%
2023-03-31 $3.37B $28.16B 12.06%
2022-12-31 $3.51B $27.40B 12.81%
2022-09-30 $3.76B $28.54B 14.01%
2022-06-30 $3.73B $27.70B 14.44%
2022-03-31 $3.70B $25.80B 14.98%
2021-12-31 $3.62B $25.34B 15.07%
2021-09-30 $3.20B $24.39B 14.23%
2021-06-30 $3.25B $23.33B 14.98%
2021-03-31 $2.67B $22.89B 12.82%
2020-12-31 $2.27B $19.44B 11.23%
2020-09-30 $2.12B $21.04B 10.39%
2020-06-30 $1.56B $19.85B 7.72%
2020-03-31 $1.77B $20.52B 8.77%
2019-12-31 $1.48B $20.06B 7.38%
2019-09-30 $4.00B $20.22B 19.91%
2019-06-30 $4.02B $19.75B 20.58%
2019-03-31 $3.78B $20.08B 19.89%
2018-12-31 $3.99B $20.35B 21.75%
2018-09-30 $2.27B $17.84B 13.20%
2018-06-30 $2.63B $17.76B 15.68%
2018-03-31 $2.80B $17.34B 17.35%
2017-12-31 $2.94B $15.90B 18.75%
2017-09-30 $2.06B $16.21B 13.25%
2017-06-30 $1.82B $15.14B 11.98%
2017-03-31 $1.71B $15.43B 11.37%
2016-12-31 $1.80B $15.55B 12.34%
2016-09-30 $1.65B $14.50B 11.56%
2016-06-30 $1.55B $14.52B 10.64%
2016-03-31 $1.58B $13.86B 10.67%
2015-12-31 $1.25B $14.27B 8.19%
2015-09-30 $1.42B $15.60B 9.13%
2015-06-30 $1.35B $15.38B 8.63%
2015-03-31 $1.37B $15.60B 8.79%
2014-12-31 $1.50B $15.69B 9.63%
2014-09-30 $1.56B $15.64B 10.23%
2014-06-30 $1.68B $15.39B 11.26%
2014-03-31 $1.70B $15.41B 11.67%
2013-12-31 $1.60B $14.70B 11.27%
2013-09-30 $1.56B $14.28B 11.31%
2013-06-30 $1.35B $13.76B 9.92%
2013-03-31 $0.85B $13.89B 6.28%
2012-12-31 $0.73B $13.39B 7.23%
2012-09-30 $0.55B $13.22B 5.36%
2012-06-30 $0.64B $13.54B 9.14%
2012-03-31 $0.60B 8.09%
2011-12-31 $0.84B $14.62B 11.40%
2011-09-30 $0.75B 20.19%
2011-06-30 $0.70B $14.90B 9.87%
2011-03-31 $1.05B 30.94%
2010-12-31 $0.84B 24.73%
2010-09-30 $0.83B $13.59B 24.53%
2010-06-30 $0.77B inf%
2010-03-31 $0.69B inf%
2009-12-31 $0.51B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.882B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.684B 28.35
Chugai Pharmaceutical (CHGCY) Japan $69.441B 27.05
Takeda Pharmaceutical (TAK) Japan $41.205B 8.58
Sandoz Group AG (SDZNY) Switzerland $18.766B 0.00
Astellas Pharma (ALPMY) Japan $17.138B 15.78
United Therapeutics (UTHR) United States $16.294B 16.03
Neurocrine Biosciences (NBIX) United States $14.266B 37.77
Summit Therapeutics (SMMT) United States $13.163B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Madrigal Pharmaceuticals (MDGL) United States $7.392B 0.00
Orion OYJ (ORINY) Finland $6.424B 18.06
Ionis Pharmaceuticals (IONS) United States $5.283B 0.00
Corcept Therapeutics (CORT) United States $5.223B 39.56
Grifols, S.A (GRFS) Spain $5.012B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.764B 0.00
PTC Therapeutics (PTCT) United States $3.389B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.688B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.614B 11.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
NewAmsterdam Pharma (NAMS) Netherlands $2.305B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.062B 0.00
Soleno Therapeutics (SLNO) United States $1.859B 0.00
Indivior (INDV) United States $1.634B 6.66
Dyne Therapeutics (DYN) United States $1.615B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Evotec AG (EVO) Germany $1.545B 0.00
Xencor (XNCR) United States $1.442B 0.00
Harrow (HROW) United States $1.306B 0.00
Ocular Therapeutix (OCUL) United States $1.291B 0.00
Guardian Pharmacy Services (GRDN) United States $1.266B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.155B 0.00
ARS Pharmaceuticals (SPRY) United States $1.092B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 5.79
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Cronos Group (CRON) Canada $0.757B 0.00
Bioventus (BVS) United States $0.753B 23.79
Relay Therapeutics (RLAY) United States $0.745B 0.00
USANA Health Sciences (USNA) United States $0.646B 11.97
Ironwood Pharmaceuticals (IRWD) United States $0.634B 0.00
Oruka Therapeutics (ORKA) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.507B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Altimmune (ALT) United States $0.489B 0.00
OmniAb (OABI) United States $0.486B 0.00
Savara (SVRA) United States $0.477B 0.00
ProKidney (PROK) United States $0.472B 0.00
Verve Therapeutics (VERV) United States $0.468B 0.00
Esperion Therapeutics (ESPR) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.443B 5.17
Zevra Therapeutics (ZVRA) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.432B 0.00
KalVista Pharmaceuticals (KALV) United States $0.388B 0.00
Akebia Therapeutics (AKBA) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Korro Bio (KRRO) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.286B 116.07
Jupiter Neurosciences (JUNS) United States $0.283B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 15.63
4D Molecular Therapeutics (FDMT) United States $0.255B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Heron Therapeutics (HRTX) United States $0.236B 0.00
Larimar Therapeutics (LRMR) United States $0.234B 0.00
Profound Medical (PROF) Canada $0.227B 0.00
Lexeo Therapeutics (LXEO) United States $0.211B 0.00
Inhibikase Therapeutics (IKT) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.190B 0.00
CytoDyn (CYDY) United States $0.183B 0.00
MediWound (MDWD) Israel $0.180B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
Silence Therapeutics (SLN) United Kingdom $0.179B 0.00
Lyell Immunopharma (LYEL) United States $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.176B 0.00
Acrivon Therapeutics (ACRV) United States $0.170B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.144B 0.00
Cassava Sciences (SAVA) United States $0.136B 0.00
Nanobiotix S.A (NBTX) France $0.133B 0.00
Champions Oncology (CSBR) United States $0.131B 0.00
Telomir Pharmaceuticals (TELO) United States $0.122B 0.00
Metagenomi (MGX) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Inotiv (NOTV) United States $0.114B 0.00
ElectroCore (ECOR) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.092B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Century Therapeutics (IPSC) United States $0.084B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Journey Medical (DERM) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.080B 20.91
ESSA Pharma (EPIX) Canada $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Galectin Therapeutics (GALT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
FibroGen (FGEN) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
OptiNose (OPTN) United States $0.053B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.052B 0.00
AlloVir (ALVR) United States $0.051B 0.00
VYNE Therapeutics (VYNE) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Scienture Holdings (SCNX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.040B 0.00
BioVie (BIVI) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Traws Pharma (TRAW) United States $0.024B 0.00
DURECT (DRRX) United States $0.024B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SciSparc (SPRC) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Conduit Pharmaceuticals (CDT) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.98